2013.gada 22.janvāra Ministru kabineta noteikumi Nr.47 "Farmakovigilances kārtība"

These rules establish the procedures for monitoring the safety of medicines once they are on the market. They aim to ensure that any adverse reactions or risks associated with medicines are identified and managed promptly. This affects pharmaceutical companies, healthcare professionals, and ultimately patients, by ensuring that medicines remain safe for use and that potential risks are communicated effectively.